Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 24 (7), 903-907
- https://doi.org/10.1016/s0197-4580(03)00007-1
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Endogenous Methylarginines Regulate Neuronal Nitric-oxide Synthase and Prevent Excitotoxic InjuryOnline Journal of Public Health Informatics, 2002
- Alzheimer Disease as a Vascular DisorderStroke, 2002
- Inhibitory Action of Nitric Oxide on Circulating Tumor Necrosis Factor-Induced NF-κB Activity and COX-2 Transcription in the Endothelium of the Brain CapillariesJournal of Neuropathology and Experimental Neurology, 2001
- Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humansClinical Science, 2001
- Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham StudyAnnals of Internal Medicine, 1999
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer DiseaseArchives of Neurology, 1998
- Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive DiseaseCirculation, 1997
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.JCI Insight, 1992